Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome.
Serial 2-channel 24 h dynamic ECGs in 7 patients who were referred with the "tachy-brady" syndrome for consideration for permanent cardiac pacing revealed: 1. atrial premature beats (APBs) which were conducted to the ventricles normally or aberrantly; 2. intermittent atrial bigeminy with block towards the ventricles (this rhythm mimicked sinus bradycardia with ventricular rates of 38-45 beats/min and the ectopic P waves were visible on only one of the ECG channels); 3. paroxysms of atrial fibrillation initiated by closely coupled APBs. These findings suggested that both the ventricular bradycardia and the atrial fibrillation were caused by frequent APBs and that pacing therapy was unnecessary. Disopyramide was given to 5 patients resulting in suppression of the arrhythmia and relief of symptoms. In one patient there was spontaneous resolution and one patient refused treatment. This variant of the "tachy-brady" syndrome can be successfully treated by suppression of abnormal atrial impulse formation without recourse to pacemaker implantation.
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000150:complications* / Q000209:etiology; D001919:Bradycardia / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D005117:Cardiac Complexes, Premature / Q000150:complications*; D004206:Disopyramide / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006325:Heart Atria; D006327:Heart Block / Q000150:complications* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D013610:Tachycardia / Q000145:classification / Q000188:drug therapy / Q000209:etiology
D004206:Disopyramide